2013
DOI: 10.1002/clc.22096
|View full text |Cite
|
Sign up to set email alerts
|

Left Ventricular Assist Devices and Gastrointestinal Bleeding: A Narrative Review of Case Reports and Case Series

Abstract: Patients with LVADs have frequent GI bleeds, especially from arteriovenous malformations, which can occur throughout the GI tract. Most diagnostic and therapeutic interventions can be used safely in these patients. The pathogenesis of the GI bleeding in these patients may involve the use of anticoagulant medications, the formation of arteriovenous malformations, loss of von Willebrand factor activity, and mucosal ischemia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
62
0
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 89 publications
(63 citation statements)
references
References 58 publications
0
62
0
1
Order By: Relevance
“…The abdominal aorta was chosen for the measurements because patients with PVADs typically do not suffer from gastrointestinal bleeding, whereas patients on continuous-flow VADs show a high incidence of such complication (8,11,22). Consequently, abdominal WI patterns under PVAD support should yield insight into what type of hemodynamic disturbance is acceptable in that region.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The abdominal aorta was chosen for the measurements because patients with PVADs typically do not suffer from gastrointestinal bleeding, whereas patients on continuous-flow VADs show a high incidence of such complication (8,11,22). Consequently, abdominal WI patterns under PVAD support should yield insight into what type of hemodynamic disturbance is acceptable in that region.…”
Section: Discussionmentioning
confidence: 99%
“…At these PS, the LV and PVAD waves seem to add or cancel each other in the peripheral circulation, resulting in a high or a low blood flow pulsatility, respectively. Blood flow pulsatility in VAD patients is important with respect to end-organ perfusion and adverse events such as gastrointestinal bleeding or peripheral vascular stiffening (8,9,11,29). Therefore, the long-term use of the PS between 40 and 60% should probably be avoided in PVADs until solid clinical data on safety and efficacy for various PS are available.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The main causes of the GI bleeding in these patients include the use of anticoagulant medications, the formation of arteriovenous malformations, loss of von Willebrand factor activity, and mucosal ischemia. 26 Pump thrombosis has been one of the common indications for pump exchange. Given the decrease in survival after each subsequent pump exchange, the prevention of pump thrombosis and pump malfunction are critical.…”
Section: Complications Of Lvads Therapymentioning
confidence: 99%
“…Tais condições extraordinárias podem causar danos ao sangue tais como hemólise, ativação de plaquetas, alteração da cascata da coagulação, trombose e embolia, redução da funcionalidade dos glóbulos brancos do sangue (leucócitos) e destruição do fator de von Willebrand (Dassanayaka et al, 2013), (Egger et al, 2013), (Islam et al, 2013), (Birschmann et al, 2014), (Bartoli et al, 2014a), (Bartoli et al, 2014b), (Bartoli et al, 2014c), (Restle et al, 2015).…”
Section: Suporte Circulatório Mecânicounclassified